Introducing a New Polymerase Chain Reaction Panel-Based Cerebrospinal Fluid Evaluation for Encephalitis and

Fabian Sidler1, Pascal Bittel2, Jonas Marschall3,4

  • 1Department of Visceral Surgery and Medicine, Inselspital Bern University Hospital, University of Bern, Bern, Switzerland.

Insights

The new meningitis/encephalitis polymerase chain reaction panel did not shorten antibiotic treatment or hospital stays. This diagnostic tool did not increase pathogen-specific diagnoses for common causes like Streptococcus or Listeria.

Area of Science:

  • Infectious Disease
  • Clinical Diagnostics
  • Microbiology

Background:

  • Meningitis and encephalitis are serious infections requiring prompt diagnosis and treatment.
  • Empiric antibiotic therapy is often initiated before a definitive pathogen is identified.
  • Novel diagnostic panels aim to improve the speed and accuracy of pathogen detection.

Purpose of the Study:

  • To evaluate the clinical impact of a diagnostic meningitis/encephalitis polymerase chain reaction (PCR) panel.
  • To assess whether the PCR panel shortened empiric antibiotic treatment duration.
  • To determine if the panel affected hospitalization length or increased pathogen-specific diagnoses.

Main Methods:

  • Retrospective analysis of patient data before and after the introduction of the meningitis/encephalitis PCR panel.
  • Comparison of empiric antibiotic treatment duration for Streptococcus and Neisseria meningitidis.
  • Evaluation of hospitalization duration and rates of pathogen-specific diagnoses.

Main Results:

  • Introduction of the PCR panel did not significantly shorten empiric antibiotic treatment duration for streptococcal/meningococcal infections (-1 day; P = .16).
  • Hospitalization duration also showed no significant change (-2 days; P = .86).
  • Empiric treatment durations for Herpesviridae and Listeria monocytogenes remained unchanged, and pathogen-specific diagnoses did not increase.

Conclusions:

  • The diagnostic meningitis/encephalitis PCR panel did not demonstrate a significant impact on reducing empiric antibiotic use or hospitalization length in this analysis.
  • The panel did not lead to an increase in specific pathogen identification compared to previous diagnostic approaches.
  • Further studies may be needed to explore the utility and optimal implementation of such panels in clinical practice.

Related Concept Videos

Bacterial Meningitis01:24

Bacterial Meningitis

Bacterial meningitis is a severe infectious disease involving inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It occurs when pathogenic bacteria cross the blood–brain barrier and enter the cerebrospinal fluid. Common causative organisms include Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b, Listeria monocytogenes, and Escherichia coli K1. The exact route of entry varies by pathogen and host condition.Routes of Entry...
Viral Meningitis01:18

Viral Meningitis

Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...
Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
Encephalitis l: Introduction01:19

Encephalitis l: Introduction

Encephalitis is inflammation of the brain parenchyma, most often due to infections or autoimmune processes. It presents with neuropsychiatric features such as fever, altered mental status, behavioral changes, cognitive dysfunction, seizures, focal deficits, and sometimes autonomic instability. In some cases, the meninges are also involved, resulting in meningoencephalitis.Infectious CausesInfectious encephalitis is most commonly viral but can also result from bacterial, fungal, or parasitic...
Encephalitis ll: Pathophysiology01:26

Encephalitis ll: Pathophysiology

Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...